Chemotherapy (CHT) adjuvant strategies and reasons for choice in breast cancer (BC) patients (pts): results from the national oncological research observatory on adjuvant therapy (NORA)

被引：0
|
作者：
Mustacchi, G. [1 ]
Cazzaniga, M. [1 ]
Pronzato, P. [1 ]
Di Costanzo, F. [1 ]
Floriani, I. [1 ]
De Matteis, A. [1 ]
机构：
[1] Univ Trieste, Trieste, Italy
来源：
EJC SUPPLEMENTS | 2004年 / 2卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(04)90665-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [21] Incidence of amenorrhea (A) in breast cancer (BC) patients (pts) ≤40 years of age after paclitaxel (T)-based adjuvant chemotherapy (CT).
    Fornier, MN
    Modi, S
    Hudis, CA
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S159 - S159
  • [22] Pathological characteristics and clinical outcome in triple-negative breast cancer (BC) patients (PTS): Results from the NORA study
    Cazzaniga, M. E.
    Mustacchi, G.
    Pronzato, P.
    Di Costanzo, F.
    De Matteis, A.
    Ravaioli, A.
    Gamucci, T.
    Brugia, M.
    Bari, M.
    Rulli, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Does the estrogen receptor status influence survival of pCR breast cancer (BC) patients (pts) after primary chemotherapy (CHT)? Results of a multicenter study
    Cazzaniga, M. E.
    Ionta, M. T.
    Barni, S.
    Barca, M.
    Eltrudis, F.
    Petrelli, F.
    Trogu, A.
    Guerzoni, D.
    Minerba, L.
    Massidda, B.
    EJC SUPPLEMENTS, 2007, 5 (04): : 206 - 206
  • [24] Effect of creatinine clearance (CrCl) on patterns of toxicity in breast cancer (BC) patients (pts) age 65 and older receiving adjuvant chemotherapy.
    Hurria, A
    Panageas, K
    Brogan, K
    Norton, L
    Howard, J
    Hudis, C
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S160 - S160
  • [25] Incidence of chemotherapy (CT)-induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T)
    Basso, Enrico
    Rossi, Luigi
    Tomao, Federica
    Papa, Anselmo
    Zaccarelli, Eleonora
    Spinelli, Gian Paolo
    Lo Russo, Giuseppe
    Zoratto, Federica
    Giordani, Erika
    Alberti, Antonio Maria
    Verrico, Monica
    Strudel, Martina
    Pasciuti, Giulia
    Stati, Valeria
    Rinaldi, Giulia
    Tomao, Silverio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Dose reduction (DR) due to chemotherapy induced peripheral neuropathy (CIPN) in breast cancer (BC) patients (pts) in the neoadjuvant/adjuvant settings.
    Bhatnagar, Bhavana
    Gilmore, Steven
    Goloubeva, Olga G.
    Wang, Lulu
    Medeiros, Michelle
    Chumsri, Saranya
    Tkaczuk, Katherine Hanna
    Edelman, Martin J.
    Bao, Ting
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Utilization of adjuvant therapy in Medicaid and uninsured seminoma patients: Results from the National Cancer Database
    Paly, Jonathan J.
    Lin, Chun Chieh
    Gray, Phillip John
    Jemal, Ahmedin
    Efstathiou, Jason Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [28] ADJUVANT CHEMOTHERAPY WITH AND WITHOUT TAMOXIFEN IN THE TREATMENT OF PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT TRIAL
    FISHER, B
    REDMOND, C
    BROWN, A
    FISHER, ER
    WOLMARK, N
    BOWMAN, D
    PLOTKIN, D
    WOLTER, J
    BORNSTEIN, R
    LEGAULTPOISSON, S
    SAFFER, EA
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) : 459 - 471
  • [29] Dose-dense adjuvant chemotherapy in early breast cancer patients: Results from a randomized trial
    Venturini, M
    Del Mastro, L
    Aitini, E
    Baldini, E
    Caroti, C
    Contu, A
    Testore, F
    Brema, F
    Pronzato, P
    Cavazzini, G
    Sertoli, MR
    Canavese, G
    Rosso, R
    Bruzzi, P
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (23): : 1724 - 1733
  • [30] THE VALUE OF CARCINOEMBRYONIC ANTIGEN (CEA) DETERMINATION IN PREDICTING DISEASE RECURRENCE (RD) IN BREAST-CANCER (BC) PATIENTS (PTS) TREATED WITH ADJUVANT CHEMOTHERAPY (ACT)
    THERIAULT, RL
    HORTOBAGYI, GN
    FRYE, D
    FRITSCHE, H
    HOLMES, FA
    BUZDAR, AU
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 199 - 199
12345